Home/Filings/4/0001628280-25-041109
4//SEC Filing

Greco Theresa 4

Accession 0001628280-25-041109

CIK 0001448431other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 3:17 PM ET

Size

7.5 KB

Accession

0001628280-25-041109

Insider Transaction Report

Form 4
Period: 2025-08-21
Greco Theresa
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2025-08-21+15,62575,981 total
  • Award

    Stock Option

    2025-08-21+35,15635,156 total
    Exercise: $16.14From: 2026-08-21Exp: 2030-08-21Common Stock (35,156 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.
  • [F2]The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1
  • filerCIK 0001998771

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 3:17 PM ET
Size
7.5 KB